In an extensive evaluation that included more than 600 subjects with hypertension, Mosso et al. [4] found that the prevalence of aldosteronism increases according to the severity of the hypertension.
The emerging role of aldosterone in hypertension and cardiovascular diseases has prompted a renewal of interest in therapeutic approaches designed to interfere with the action of this ...
Completed enrollment in pivotal Advance-HTN trial and anticipate topline data in March 2025 – – Completed enrollment ahead of schedule in pivotal Phase 3 Launch-HTN trial and anticipate delivering ...